Literature DB >> 19463083

People with low back pain typically need to feel 'much better' to consider intervention worthwhile: an observational study.

Manuela L Ferreira1, Paulo H Ferreira, Robert D Herbert, Jane Latimer.   

Abstract

QUESTIONS: How much of an effect do five common physiotherapy interventions need to have for patients with low back pain to perceive they are worth their cost, discomfort, risk, and incovenience? Are there any differences between the interventions? Do specific characteristics of people with low back pain predict the smallest important difference?
DESIGN: Cross-sectional, observational study. PARTICIPANTS: 77 patients with non-specific low back pain who had not yet commenced physiotherapy intervention. OUTCOME MEASURES: The smallest worthwhile effect was measured in terms of global perceived change (0 to 4) and percentage perceived change.
RESULTS: Participants perceived that intervention would have to make them 'much better', which corresponded to 1.7 (SD 0.7) on the 4-point scale, or improve their symptoms by 42% (SD 23), to make it worthwhile. There was little distinction made between interventions, regardless of whether smallest worthwhile effects were quantified as global perceived change (p = 0.09) or percentage perceived change (p = 1.00). Severity of symptoms independently (p = 0.01) predicted percentage perceived change explaining 9% of the variance, so that for each increase in severity of symptoms of 1 point out of 10 there was an increase of 4% in the percentage perceived change that participants considered would make intervention worthwhile.
CONCLUSIONS: Typically people with low back pain feel that physiotherapy intervention must reduce their symptoms by 42%, or make them feel 'much better' for intervention to be worthwhile.

Entities:  

Mesh:

Year:  2009        PMID: 19463083     DOI: 10.1016/s0004-9514(09)70042-x

Source DB:  PubMed          Journal:  Aust J Physiother        ISSN: 0004-9514


  6 in total

1.  Individual patient monitoring in daily clinical practice: a critical evaluation of minimal important change.

Authors:  Jos Hendrikx; Jaap Fransen; Wietske Kievit; Piet L C M van Riel
Journal:  Qual Life Res       Date:  2014-09-25       Impact factor: 4.147

2.  The importance of determining the clinical significance of research results in physical therapy clinical research.

Authors:  Susan Armijo-Olivo
Journal:  Braz J Phys Ther       Date:  2018-02-14       Impact factor: 3.377

3.  Specific treatment of problems of the spine (STOPS): design of a randomised controlled trial comparing specific physiotherapy versus advice for people with subacute low back disorders.

Authors:  Andrew J Hahne; Jon J Ford; Luke D Surkitt; Matthew C Richards; Alexander Y P Chan; Sarah L Thompson; Rana S Hinman; Nicholas F Taylor
Journal:  BMC Musculoskelet Disord       Date:  2011-05-20       Impact factor: 2.362

4.  Adipose derived mesenchymal stem cell therapy in the treatment of isolated knee chondral lesions: design of a randomised controlled pilot study comparing arthroscopic microfracture versus arthroscopic microfracture combined with postoperative mesenchymal stem cell injections.

Authors:  Julien Freitag; Jon Ford; Dan Bates; Richard Boyd; Andrew Hahne; Yuanyuan Wang; Flavia Cicuttini; Leesa Huguenin; Cameron Norsworthy; Kiran Shah
Journal:  BMJ Open       Date:  2015-12-18       Impact factor: 2.692

Review 5.  Pain relief that matters to patients: systematic review of empirical studies assessing the minimum clinically important difference in acute pain.

Authors:  Mette Frahm Olsen; Eik Bjerre; Maria Damkjær Hansen; Jørgen Hilden; Nino Emanuel Landler; Britta Tendal; Asbjørn Hróbjartsson
Journal:  BMC Med       Date:  2017-02-20       Impact factor: 8.775

6.  Patients' perceived needs for allied health, and complementary and alternative medicines for low back pain: A systematic scoping review.

Authors:  Louisa Chou; Tom A Ranger; Waruna Peiris; Flavia M Cicuttini; Donna M Urquhart; Andrew M Briggs; Anita E Wluka
Journal:  Health Expect       Date:  2018-07-07       Impact factor: 3.377

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.